![](/img/cover-not-exists.png)
PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United Kingdom
Samyshkin, Y., Hertel, N., Griebsch, I.Volume:
14
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2011.08.1171
Date:
November, 2011
File:
PDF, 72 KB
english, 2011